These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 13019601)

  • 21. [Cytostasis due to triethylene melamine (TEM) in lymphogranulomatosis and chronic leukemia].
    NEUMANN C
    Klin Wochenschr; 1952 Dec; 30(47-48):1105-8. PubMed ID: 13023980
    [No Abstract]   [Full Text] [Related]  

  • 22. Results in the use of triethylene melamine (TEM) in malignant lymphomas and chronic leukemias.
    MEZA ARRAU C; NIJAMKIN A
    Rev Med Chil; 1955 Feb; 83(2):90-5. PubMed ID: 14385308
    [No Abstract]   [Full Text] [Related]  

  • 23. The role of chemotherapy in the management of malignant lymphomas and leukemias.
    RUNDLES RW; BARTON WB; COONRAD EV
    South Med J; 1953 Mar; 46(3):259-68. PubMed ID: 13038539
    [No Abstract]   [Full Text] [Related]  

  • 24. [On the treatment of malignant lymphogranulomatosis, polycythemia vera and myelomatosis with nitrogen perite].
    IVERSEN K; KJERULF-JENSEN K
    Acta Clin Belg; 1948; 3(2):138-50. PubMed ID: 18875401
    [No Abstract]   [Full Text] [Related]  

  • 25. Triethylene melamine in the treatment of Hodgkin's disease and other lymphomas.
    ROTTINO A
    N Y State J Med; 1952 Feb; 52(3):346-8. PubMed ID: 14899689
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of leukemia and lymphomata with triethylene melamine.
    WALSH JR; PRATT PT; GRAHAM WE; ZIMMERMAN HJ
    Acta Haematol; 1954 Jun; 11(6):329-38. PubMed ID: 13170978
    [No Abstract]   [Full Text] [Related]  

  • 27. Triethylene melamine (TEM) in the treatment of malignant lymphoid disease.
    HAMBLY CK; ROBERTSON TI
    Med J Aust; 1955 Jun; 42(1 25):900-11. PubMed ID: 13243982
    [No Abstract]   [Full Text] [Related]  

  • 28. A trial of beta-naphthyldi-2-chloroethylamine in leukemia, Hodgkin's disease, and allied diseases.
    MATTHEWS WB
    Lancet; 1950 May; 1(6611):896-9. PubMed ID: 15416069
    [No Abstract]   [Full Text] [Related]  

  • 29. [Further studies on reticuloendothelial clearance of macromolecules. V. Effect of nitrogen mustard, ethylurethane and triethylene melamine].
    FRIMMER M
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1953; 220(4):334-7. PubMed ID: 13132955
    [No Abstract]   [Full Text] [Related]  

  • 30. Triethylene melamine in the treatment of lymphomas and other neoplastic diseases.
    BURTNER OW; JENSEN LC; RUMBALL JM
    Ann Intern Med; 1953 Jun; 38(6):1222-44. PubMed ID: 13065973
    [No Abstract]   [Full Text] [Related]  

  • 31. [Efficacy and limitations of karyoklastic therapy of leukosis, lymphogranulomatosis, and malignant tumors in childhood].
    WEICKER H
    Kinderarztl Prax; 1950; 18():143-50. PubMed ID: 14785133
    [No Abstract]   [Full Text] [Related]  

  • 32. Mannomustine in treatment of leukaemias, polycythaemia, and malignant disorders.
    BARLOW AM; LEEMING JT; WILKINSON JF
    Br Med J; 1959 Aug; 2(5146):208-13. PubMed ID: 13671231
    [No Abstract]   [Full Text] [Related]  

  • 33. Triethylene melamine in the treatment of lymphomas and leukemias.
    KARNOFSKY DA
    Med Clin North Am; 1954 Mar; 11():541-54. PubMed ID: 13153527
    [No Abstract]   [Full Text] [Related]  

  • 34. [CLASSIFICATION OF LEUKEMIA BY SENSITIVITY OF CELLS TO DRUGS].
    KIMURA K; KURITA S
    Nihon Ketsueki Gakkai Zasshi; 1963 Feb; 26():94-100. PubMed ID: 14043481
    [No Abstract]   [Full Text] [Related]  

  • 35. Triethylene melamine in the treatment of certain blood diseases.
    COLARUSSO A
    Riforma Med; 1952 Oct; 66(40):1071-3. PubMed ID: 13014833
    [No Abstract]   [Full Text] [Related]  

  • 36. [Triethylene melamine treatment of leukemia and lymphogranulomatosis].
    CAKMAKCI A
    Turk Tip Cemiy Mecm; 1954 Jun; 20(6):290-314. PubMed ID: 13217043
    [No Abstract]   [Full Text] [Related]  

  • 37. Nitrogen mustard as a therapeutic agent for Hodgkin's disease, lymphosarcoma and leukemia.
    WINTROBE MM; HUGULEY CM
    Ann Intern Med; 1947 Oct; 27(4):529-40. PubMed ID: 20268426
    [No Abstract]   [Full Text] [Related]  

  • 38. [Nitrogen mustard sags by lymphogranulomatosis maligna, polycytaemia and myelomatosis].
    IVERSEN K; KJERULF-JENSEN K
    Nord Med; 1948 Jun; 38(26):1248-52. PubMed ID: 18888857
    [No Abstract]   [Full Text] [Related]  

  • 39. FURTHER OBSERVATIONS ON LATE SOMATIC EFFECTS OF RADIOMIMETIC CHEMICALS AND X-RAYS IN MICE.
    CONKLIN JW; UPTON AC; CHRISTENBERRY KW
    Cancer Res; 1965 Jan; 25():20-8. PubMed ID: 14254989
    [No Abstract]   [Full Text] [Related]  

  • 40. Nitrogen mustard therapy; the use of methyl bis (B chloroethyl) amine hydrochloride in Hodgkin's disease, leukemia, lymphosarcoma and cancer of the lung.
    BEN-ASHER S
    Am J Med Sci; 1949 Feb; 217(2):162-8. PubMed ID: 18109277
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.